SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-027909
Filing Date
2021-05-19
Accepted
2021-05-19 16:09:10
Documents
3
Period of Report
2021-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea141356-8k_emmauslife.htm 8-K 19273
2 LETTER DATED MAY 19, 2020 FROM BAKER TILLY US, LLP ea141356ex99-1_emmauslife.htm EX-99.1 4750
3 GRAPHIC image_001.jpg GRAPHIC 3448
  Complete submission text file 0001213900-21-027909.txt   30291
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 21940378
SIC: 2834 Pharmaceutical Preparations